» Articles » PMID: 34915190

Fast and Versatile Analysis of Liposome Encapsulation Efficiency by NanoParticle Exclusion Chromatography

Overview
Journal J Chromatogr A
Publisher Elsevier
Specialty Chemistry
Date 2021 Dec 16
PMID 34915190
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Liposomes are an attractive drug delivery platform for a wide variety of pharmaceutical molecules. Encapsulation efficiency, which refers to the amount of drug contained inside liposomes compared with the total amount of drug, is a critical quality attribute of liposome products, as the free drug in a liposomal formulation may cause toxicity or undesired biodistribution. The determination of encapsulation efficiency requires the measurement of at least two of the three drug populations: total drug, encapsulated drug and free drug. However, direct measurement of the encapsulated drug and free drug remains a challenging analytical task. Nanoparticle exclusion chromatography (nPEC), an emerging high-performance liquid chromatography (HPLC) technique, has shown great potential in separating and quantifying the free drug in liposomal formulations. In this study, nPEC was systematically evaluated for two representative liposomal formulations containing either hydrophilic or hydrophobic small molecule drugs. It is reported for the first time that the insoluble free drug suspended in the aqueous formulation can be directly measured by nPEC. This free drug in the suspension sample was quantified with excellent accuracy and precision. On the other hand, the total drug measurement from dissociated liposomes was confirmed by the benchmark methodology of reversed phase liquid chromatography (RPLC). The facile quantitation of free and total drug in the liposome formulation enables the fast and accurate determination of the encapsulation efficiency, which can be used to guide the formulation development and characterize the product quality.

Citing Articles

Development and Evaluation of Aloperine-Loaded Nanostructured Lipid Carriers for the Treatment of Pulmonary Arterial Hypertension.

Liu H, Liu S, Ma P, Ma L, Liu Y, Zhao F Int J Nanomedicine. 2025; 20:871-886.

PMID: 39867311 PMC: 11761852. DOI: 10.2147/IJN.S489133.


Ultrasound-triggered drug release and cytotoxicity of microbubbles with diverse drug attributes.

Chuang C, Lin C, Yeh C Ultrason Sonochem. 2024; 112():107182.

PMID: 39631357 PMC: 11655813. DOI: 10.1016/j.ultsonch.2024.107182.


HER-2 Receptor and αvβ3 Integrin Dual-Ligand Surface-Functionalized Liposome for Metastatic Breast Cancer Therapy.

Arya D, Deshpande H, Kumar A, Chidambaram K, Pandey P, Anjum S Pharmaceutics. 2024; 16(9).

PMID: 39339166 PMC: 11435421. DOI: 10.3390/pharmaceutics16091128.


Development of an advanced separation and characterization platform for mRNA and lipid nanoparticles using multi-detector asymmetrical flow field-flow fractionation.

Gao Z, Lin J, Su W, Zhang K, Gruenhagen J, Zhong W Anal Bioanal Chem. 2024; 416(24):5281-5293.

PMID: 39102094 DOI: 10.1007/s00216-024-05455-x.


Oral Delivery of Astaxanthin via Carboxymethyl Chitosan-Modified Nanoparticles for Ulcerative Colitis Treatment.

Zhang W, Zhang X, Lv X, Qu A, Liang W, Wang L Molecules. 2024; 29(6).

PMID: 38542929 PMC: 10975021. DOI: 10.3390/molecules29061291.